Laurence Dawkins-Hall

0 Followers

I have an HCPC accredited Bio medical sciences degree (1987). I have 15 years experience of molecular/cell biology and protein biochemistry and 10 years experience of genetics and genomics, including transcriptomics & genome laboratories in the USA. I possess 5 years drug discovery experience. I have 40 publications, comprising peer reviewed publications, conference papers & text book materials culminating in 350 citations . I participated in a project which was the first to describe and make formal submissions to Gen Bank regarding a murine Cadherin (DCS-2), cf. #L33779 I am a review Editor for Frontiers Microbiology, infectious diseases I have standard DNA, RNA & protein techniques...

compound library screens recombinant protein expression assay development extended gene expression networks micro arrays parasitology radio ligand assay drug discovery drug ligand modelling dna sequencing core facilities trypanosomiasis genomics enzyme kinetics rna editing in silico modelling cycle sequencing abrf bacs automated dna sequencing dsrg genetics infectious diseases qtl's microbial therapeutics transcriptomics exome sequencing rt pcr snp detection parasitology drug discovery

Präsentationen
Dokumente
Infografiken

Aktuellste Beliebteste SlideShares

06 isafg p77 genome wide expression consequences of a disease resistance qtl are strongly influenced by genetic background oral presentation

Vor 7 Jahren • 64 Aufrufe

Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist hits_progress report #4_further hit titrations

Vor 7 Jahren • 51 Aufrufe

Lab talk 201109 radioligand assay for validating in slico predicted rel1 antagonists_progress #3_titration of initial hits

Vor 7 Jahren • 37 Aufrufe

Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhibitors progress report #2_identification of initial hits

Vor 7 Jahren • 37 Aufrufe

Lab talk 060809 radioligand assay to validate in slico predicted rel inhibitors_progress report #1_principles and initial screen

Vor 7 Jahren • 40 Aufrufe

Laurence Dawkins-Hall

06 isafg p77 genome wide expression consequences of a disease resistance qtl are strongly influenced by genetic background oral presentation

Lab talk 181209 radioligand assay for validating in silico rel 1 antagonist hits_progress report #4_further hit titrations

Lab talk 201109 radioligand assay for validating in slico predicted rel1 antagonists_progress #3_titration of initial hits

Lab talk 180909 radioligand assay to validate in silico predicted rel1 inhibitors progress report #2_identification of initial hits

Lab talk 060809 radioligand assay to validate in slico predicted rel inhibitors_progress report #1_principles and initial screen

Labtalk 101210 optimising fret assay_den_optimising r_rel 1 production_heat shock

Labtalk 151010 optimising fret assay_ligation buffer_[atp]_fluorophores

Lab talk 300710 optimisation of fret assay parameters_calculating km of atp substrate_den regimen

Lab talk 070510 inducing r_rel1 for establishing fret assay_ic50 studies with mordant black

Lab talk 020410 inducing rel 1 to set up ht fret assay_progress

Lab talk 190210 efficacy studies on radioligand hits_beginnings of fret assay_principles_induction of rel 1

Lab talk 020710 comparing bac r_rel 1 with e coli rrel 1 for use in fret assay

Genomic analysis of a hypertensive qtl on rat chr 1